Our top picks are in the cards above
It helps lower blood sugar in people with type 2 diabetes and supports weight loss in those with obesity
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
Our team has worked with research-grade peptides for years
The name of the semaglutide injection, as one of the sponsors of the event, was visible behind female players as they served It was curious to spot Ozempic emblazoned courtside, in a professional sporting environment, as WADA added GLP-1s to its monitored substances list and is expected to rule in 2026 on whether it will permit athletes to use them. Some industry observers argue that companies often seek to align with high-profile athletes to enhance the visibility and acceptance of GLP-1 medications
Novo Nordisk's Wegovy targets only GLP-1